These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 29079098)
1. Comparing cancer screening estimates: Behavioral Risk Factor Surveillance System and National Health Interview Survey. Sauer AG; Liu B; Siegel RL; Jemal A; Fedewa SA Prev Med; 2018 Jan; 106():94-100. PubMed ID: 29079098 [TBL] [Abstract][Full Text] [Related]
2. Small Area Estimation of Cancer Risk Factors and Screening Behaviors in US Counties by Combining Two Large National Health Surveys. Liu B; Parsons V; Feuer EJ; Pan Q; Town M; Raghunathan TE; Schenker N; Xie D Prev Chronic Dis; 2019 Aug; 16():E119. PubMed ID: 31469068 [TBL] [Abstract][Full Text] [Related]
3. Modifiers of Cancer Screening Prevention Among Sexual and Gender Minorities in the Behavioral Risk Factor Surveillance System. Charkhchi P; Schabath MB; Carlos RC J Am Coll Radiol; 2019 Apr; 16(4 Pt B):607-620. PubMed ID: 30947895 [TBL] [Abstract][Full Text] [Related]
4. Meeting the cervical cancer screening needs of underserved women: the National Breast and Cervical Cancer Early Detection Program, 2004-2006. Tangka FK; O'Hara B; Gardner JG; Turner J; Royalty J; Shaw K; Sabatino S; Hall IJ; Coates RJ Cancer Causes Control; 2010 Jul; 21(7):1081-90. PubMed ID: 20361353 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of past-year dental visit among US adults, 1999-2010: comparison of trends and estimates between the Behavioral Risk Factor Surveillance System and three national surveys. Lin M; Li CH; Wei L; Naavaal S; Kolavic Gray S; Manz MC; Barker L J Public Health Dent; 2017 Mar; 77(2):105-114. PubMed ID: 27701758 [TBL] [Abstract][Full Text] [Related]
9. US hysterectomy prevalence by age, race and ethnicity from BRFSS and NHIS: implications for analyses of cervical and uterine cancer rates. Adam EE; White MC; Saraiya M Cancer Causes Control; 2022 Jan; 33(1):161-166. PubMed ID: 34546462 [TBL] [Abstract][Full Text] [Related]
10. Potential Biases Introduced by Conflating Screening and Diagnostic Testing in Colorectal Cancer Screening Surveillance. Becker EA; Griffith DM; West BT; Janz NK; Resnicow K; Morris AM Cancer Epidemiol Biomarkers Prev; 2015 Dec; 24(12):1850-4. PubMed ID: 26491056 [TBL] [Abstract][Full Text] [Related]
11. Cancer screening practices from National Health Interview Surveys: past, present, and future. Hiatt RA; Klabunde C; Breen N; Swan J; Ballard-Barbash R J Natl Cancer Inst; 2002 Dec; 94(24):1837-46. PubMed ID: 12488477 [TBL] [Abstract][Full Text] [Related]
12. Reversals of association for Pap, colorectal, and prostate cancer testing among Hispanic and non-Hispanic black women and men. Rakowski W; Clark MA; Rogers ML; Weitzen SH Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):876-89. PubMed ID: 21393564 [TBL] [Abstract][Full Text] [Related]
13. Examining cancer screening disparities by race/ethnicity and insurance groups: A comparison of 2008 and 2018 National Health Interview Survey (NHIS) data in the United States. Sun J; Frick KD; Liang H; Chow CM; Aronowitz S; Shi L PLoS One; 2024; 19(2):e0290105. PubMed ID: 38416784 [TBL] [Abstract][Full Text] [Related]
14. A comparison of prevalence estimates for selected health indicators and chronic diseases or conditions from the Behavioral Risk Factor Surveillance System, the National Health Interview Survey, and the National Health and Nutrition Examination Survey, 2007-2008. Li C; Balluz LS; Ford ES; Okoro CA; Zhao G; Pierannunzi C Prev Med; 2012 Jun; 54(6):381-7. PubMed ID: 22521996 [TBL] [Abstract][Full Text] [Related]
15. Comparisons of Estimates From the Behavioral Risk Factor Surveillance System and Other National Health Surveys, 2011-2016. Hsia J; Zhao G; Town M; Ren J; Okoro CA; Pierannunzi C; Garvin W Am J Prev Med; 2020 Jun; 58(6):e181-e190. PubMed ID: 32444008 [TBL] [Abstract][Full Text] [Related]
16. Tracking chronic disease and risk behavior prevalence as survey participation declines: statistics from the behavioral risk factor surveillance system and other national surveys. Fahimi M; Link M; Mokdad A; Schwartz DA; Levy P Prev Chronic Dis; 2008 Jul; 5(3):A80. PubMed ID: 18558030 [TBL] [Abstract][Full Text] [Related]
17. The influence of marital status on the use of breast, cervical, and colorectal cancer screening. Hanske J; Meyer CP; Sammon JD; Choueiri TK; Menon M; Lipsitz SR; Noldus J; Nguyen PL; Sun M; Trinh QD Prev Med; 2016 Aug; 89():140-145. PubMed ID: 27215758 [TBL] [Abstract][Full Text] [Related]
18. Associations between cervical, breast and colorectal cancer screening uptake, chronic diseases and health-related behaviours: Data from the Italian PASSI nationwide surveillance. Venturelli F; Sampaolo L; Carrozzi G; ; Zappa M; Giorgi Rossi P Prev Med; 2019 Mar; 120():60-70. PubMed ID: 30659908 [TBL] [Abstract][Full Text] [Related]
19. Changes in Cancer Screening in the US During the COVID-19 Pandemic. Fedewa SA; Star J; Bandi P; Minihan A; Han X; Yabroff KR; Jemal A JAMA Netw Open; 2022 Jun; 5(6):e2215490. PubMed ID: 35657622 [TBL] [Abstract][Full Text] [Related]
20. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013. Johnson NB; Hayes LD; Brown K; Hoo EC; Ethier KA; MMWR Suppl; 2014 Oct; 63(4):3-27. PubMed ID: 25356673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]